RAman SPectrometry Based biomarkER discoveRY for Myalgic Encephalomyelitis (RASPBERRY-ME)

The overarching goal of RASPBERRY-ME project is the characterization of the biomolecular signature of Myalgic Encephalomyelitis using Label-free Raman Spectroscopy (RS) and machine learning models.
Study of COVID-19 survivors’ profiles for detection of ME/CFS (SCOPIMED)

The purpose of this study is to capture a post-COVID-19 infected population willing to participate in phenotyping studies early in the post-COVID-19 illness progression, with an aim of providing targeted effective therapies and preventing the onset and progression of ME/CFS.
Multi-Omics Study of ME/CFS (MAESTRO)

The primary goal of this project is to complete our comprehensive analysis of the genome, methylome, miRnome, and their interactions in order to fill the gaps in our understanding of ME/CFS pathophysiology and to identify clinically useful biomarkers.
Precision Medicine for Myalgic Encephalomyelitis Drug Discovery and ClinicaI Trials (REMEDIAL)
The REMEDIAL project continues the work
commenced with MAESTRO and will lead to a
better understanding of the molecular
mechanisms underlying ME/CFS pathophysiology,
the persistence and variability of the symptoms,
and will contribute to the identification of targets
and therapeutic agents for intervention.
Dr. Alain Moreau’s paper was named a Top 100 Scientific Reports paper in 2020!
Open Medicine Foundation Canada (OMFCA) is excited to share that Dr. Alain Moreau’s paper Profile of circulating microRNAs in myalgic encephalomyelitis and their relation to symptom severity, and disease pathophysiology, has been named one of the top 100 Scientific Reports papers in 2020! Serving on OMF’s Scientific Advisory Board, Alain Moreau, Ph.D., is also Director of […]
Profile of circulating microRNAs in myalgic encephalomyelitis and their relation to symptom severity, and disease pathophysiology by Alain Moreau, PhD, Montreal Collaboration
From the desk of Dr. Alain Moreau, PhDDirector of the Collaborative Research Center at the CHU Sainte-Justine/Université de Montréal #TripleGivingTuesday Research Update Montréal ME/CFS Research CenterPaper Published in Scientific Reports On behalf of Open Medicine Foundation Canada (OMFCA), I am pleased to share that an article authored by my research team at the OMF funded ME / CFS […]
Promising Studies Underway at Montréal Research Center | #TripleGivingTuesday
From the desk of Dr. Alain Moreau, PhDDirector of the Collaborative Research Center at the CHU Sainte-Justine/Université de Montréal #TripleGivingTuesday Research Update Promising Research Underwayat Montréal Research Center I’m very pleased to share with you, a valued supporter of Open Medicine Foundation Canada (OMFCA), an update from my team at the OMF funded ME/CFS Collaborative Research […]
OMF Welcomes Alain Moreau, PhD, to our Scientific Advisory Board
Dr. Alain Moreau joins the OMF Scientific Advisory Board OMF is honored to welcome Canadian researcher, Dr. Alain Moreau, to our Scientific Advisory Board (SAB,) which is directed by Ronald W. Davis. PhD. “I initially decided to invite Dr. Moreau to join our ME / CFS Working Group because he demonstrated that he could take […]